News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dainippon Pharmaceutical , ZOEGENE Corporation Conclude Joint Research Agreement In Diabetes And Obesity


10/19/2005 5:13:07 PM

Tokyo (JCNN) - Dainippon Pharmaceutical (TSE: 4506) and ZOEGENE jointly announced on March 23 that they have entered into a joint research agreement in the fields of diabetes and obesity. Based on compounds developed by ZOEGENE, Dainippon Pharmaceutical will conduct further research in order to synthesize a candidate compound for anti-obesity and antidiabetic drugs with a new action mechanism.

Read at JCN Newswire

comments powered by Disqus
   
Obesity
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES